Reproductive Endocrinology · Neuroendocrinology

Outcome of pregnancies in women with treated or untreated hyperprolactinemia

Rossi AM, Vilska S, Heinonen PK

Published December 1995 European Journal of Obstetrics, Gynecology, and Reproductive Biology, 63(2), 143-146
DOI 10.1016/0301-2115(95)02257-0 PMID 8903770

Abstract

The outcome of 103 pregnancies in 64 women with constant hyperprolactinemia was evaluated. Seventy-eight pregnancies had been induced with bromocriptine and 25 occurred without any treatment. In all, 66% of the pregnancies ended in delivery, 17% in miscarriage, 10% in tubal pregnancy and 7% in induced abortion. The pregnancy of women with untreated hyperprolactinemia was more frequently ectopic when compared to those in women treated by bromocriptine. Obstetric complications as well as signs of tumoral enlargement during pregnancy were rare in hyperprolactinemic women treated or untreated with bromocriptine. Untreated hyperprolactinemia as a risk factor in tubal pregnancy is proposed.

Topics

By this author

Related research

Reproductive Endocrinology › Neuroendocrinology › Hyperprolactinemia · Pregnancy › Pregnancy Complications › Hypertensive Disorders · Birth and Delivery › Birth Outcomes › Maternal Morbidity
Anna-Maija Rossi, Sirpa Vilska, Pentti K. Heinonen
A Rossi, S Vilska, P Heinonen
PMID 8903770 8903770 DOI 10.1016/0301-2115(95)02257-0 10.1016/0301-2115(95)02257-0 Rossi et al. 1995, Rossi 1995